Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: LEO Pharma A/S
Woman and Man Max 99 years
LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S)
Update Il y a 4 ans
Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Psoriasis Vulgaris
To compare the clinical efficacy of once daily treatment for up to 8 weeks of calcipotriol plus betamethasone dipropionate gel with betamethasone dipropionate in the gel vehicle, calcipotriol in the g...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
LEO Pharma A/S
Update Il y a 4 ans
A Phase 2, proof of concept and dose finding study, investigating treatment efficacy of LEO 29102 cream (2.5 mg/g, 1.0 mg/g, 0.3 mg/g, 0.1 mg/g, 0.03 mg/g), LEO 29102 cream vehicle, and Elidel (Pimecrolimus) cream 10 mg/g, after cutaneous administration twice daily for 4 weeks. An international, multi-centre, prospective, randomised, double-blind, 7 arm, vehicle-controlled, parallel group study
The primary objective of the study is to identify the optimal dose of 5 different strength of LEO 29102 in the treatment of patients with the clinical diagnosis of atopic dermatitis graded as mild to ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S)
Update Il y a 4 ans
Long-term treatment of Scalp Psoriasis with Calciptriol plus Betamethasone dipropionate gel. A phase III safety study of a new gel containing calcipotriol 50mcg/g plus betamethasone 0.5 mg/g (as dipropionate) used once daily, as needed, in scalp psoriasis
To determine the safety of once daily calcipotriol plus betamethasone dipropionate gel used, as needed, for up to 52 weeks for the treatment of scalp psoriasis.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
LEO Pharma A/S
Update Il y a 4 ans
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
To compare the cumulative incidence of squamous cell carcinoma (SCC) after treatment with ingenol mebutate gel and imiquimod cream.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
LEO Pharma A/S
Update Il y a 4 ans
A clinical trial for evaluation of efficacy and safety of an aprepitant gel in itching disease (Prurigo). Eine klinische Studie zur Überprüfung der Wirksamkeit und Sicherheit von Aprepitant Gel bei einer Juckreizerkrankung (Prurigo)
To investigate the efficacy of topical treatment with aprepitant on pruritus compared to placebo, after 4 weeks of treatment Beeurteilung der Wirksamkeit von topischer Behandlung mit Aprepitant ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
LEO Pharmaceuticals Products Ltd. A/S (LEO Pharma A/S)
Update Il y a 4 ans
Safety and Efficacy of Calcipotriol plus Betamethasone Dipropionate Gel in Adolescent Patients (Aged 12 to 17 Years) with Scalp Psoriasis
The primary objective is to evaluate the safety of once daily use of calcipotriol (50 mcg/g) plus betamethasone (0.5 mg/g) (as dipropionate) gel in adolescent subjects (aged 12 to 17 years) with scalp...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
LEO Pharma A/S
Update Il y a 5 ans
LEO 90110 ointment in the treatment of psoriasis vulgaris
To compare LEO 90110 20.0 mg/g ointment to LEO 90110 ointment vehicle with respect to efficacy when administered twice daily for 8 weeks to patients with psoriasis vulgaris
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S)
Update Il y a 4 ans
A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g (LEO 80190 ointment) with hydrocortisone 10 mg/g ointment, both applied once daily in the treatment of psoriasis vulgaris on the face and intertriginous areas Calcipotriol Plus Hydrocortisone in Paediatric Patients (Aged 6 to 17 Years) with Psoriasis Vulgaris on the Face and on the Intertriginous Areas
To compare the efficacy of once daily treatment for up to 8 weeks of an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g (LEO 80190 ointment) with an ointment containing hydrocort...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
LEO Pharma A/S
Update Il y a 4 ans
Not applicable
To demonstrate that ingenol mebutate gel is efficacious in treating AKs present 8 weeks after initial field treatment (field recalcitrant) or emerging in a previously cleared field (field recurrent). ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
LEO Pharma A/S
Update Il y a 4 ans
Safety and efficacy of repeat use of Picato® 0.05% in the treatment of anogenital warts
To evaluate the safety of single treatment with Picato® 0.05% repeated up to 2 times with two weeks intervals in subjects with anogenital warts.
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
Next